<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sleep Neurology MCQ Q37</title>
</head>
<body>
    <h1>Sleep Neurology MCQ Q37</h1>
    <div>
        
    <style>
        .explanation-container {
            font-family: 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            margin: 20px 0;
            background-color: #f8f9fa;
            border-radius: 8px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
            overflow: hidden;
            padding-bottom: 10px;
        }
        .explanation-section {
            margin-bottom: 20px;
            padding: 0 20px;
        }
        .explanation-header {
            background-color: #4a69bd;
            color: white;
            padding: 10px 20px;
            margin: 0 -20px 15px -20px;
            border-radius: 4px;
            font-size: 1.2em;
            font-weight: 600;
        }
        .explanation-content {
            padding: 0 5px;
            text-align: justify;
        }
        .table-container {
            margin: 15px 0;
            overflow-x: auto;
        }
        .comparison-table {
            width: 100%;
            border-collapse: collapse;
            border-spacing: 0;
            border: 1px solid #ddd;
        }
        .comparison-table th {
            background-color: #f2f2f2;
            color: #333;
            font-weight: bold;
            text-align: left;
            padding: 10px;
            border: 1px solid #ddd;
        }
        .comparison-table td {
            padding: 10px;
            border: 1px solid #ddd;
            vertical-align: top;
        }
        .comparison-table tr:nth-child(even) {
            background-color: #f9f9f9;
        }
        .list-item {
            display: inline-block;
            margin-right: 5px;
            color: #4a69bd;
        }
        .key-point {
            font-weight: 600;
            color: #e74c3c;
        }
        .evidence {
            color: #2980b9;
        }
        .citation {
            font-style: italic;
            color: #7f8c8d;
        }
    </style>
    <div class="explanation-container"><div class="explanation-section"><h3 class="explanation-header">Conceptual Framework & Clinical Context</h3><div class="explanation-content"><div class='explanation-content'>[Exam: Part 2 2020] Restless Legs Syndrome (RLS) is a sensorimotor disorder characterized by an irresistible urge to move the legs, usually accompanied by uncomfortable sensations. Symptoms worsen at rest and in the evening, improving with movement. Key pathophysiological factors include central dopaminergic dysfunction (particularly in the A11 hypothalamic nucleus and its spinal projections) and disrupted iron homeostasis in the substantia nigra. RLS is classified as primary (idiopathic, often with genetic predisposition) or secondary, where identifiable conditions&mdash;most commonly iron deficiency and pregnancy&mdash;precipitate symptoms. Recognizing secondary causes is essential for targeted management.</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Evidence-Based Analysis</h3><div class="explanation-content"><div class='explanation-content'>Pregnancy is a well-established risk factor for secondary RLS. Prospective cohort studies report a prevalence of 10&ndash;34% in the third trimester compared to ~5% in nonpregnant controls <span class="citation">(Allen et al., Sleep Med <span class="evidence">Rev 2013</span>)</span>. Iron demands increase by 1,000 mg during pregnancy, leading to relative deficiency and impaired dopamine synthesis. Hormonal shifts (elevated estrogen and progesterone) may further modulate dopaminergic and spinal inhibitory pathways. Most cases resolve within 4&ndash;6 weeks postpartum.<br><br>The American Academy of Sleep Medicine (AASM) Clinical Practice Guideline (2016) cites pregnancy as a Level A risk factor for secondary RLS and recommends checking serum ferritin, with supplementation if <75 ng/mL. A randomized trial of intravenous ferric carboxymaltose in iron-deficient pregnant women <span class="citation">(Koch et al., Obstet <span class="evidence">Gynecol 2018</span>)</span> showed symptom reduction (p<0.01). No high-quality trials support a link between hypertension or COPD and RLS, and while diabetes mellitus&ndash;related neuropathy can mimic RLS sensations, diabetes itself does not independently confer the same risk magnitude.</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Incorrect Options Analysis</h3><div class="explanation-content"><div class='explanation-content'>B. Hypertension  <br>&ndash; No robust epidemiological data link chronic hypertension to RLS prevalence. Hypertensive patients do not show increased RLS in large cross-sectional studies <span class="citation">(Ondo et al., Mov <span class="evidence">Disord 2005</span>)</span>. Misconception: equating vascular risk factors with neuropathic symptoms.  <br><br>C. Diabetes mellitus  <br>&ndash; Diabetes can cause peripheral neuropathy with paresthesias, but true RLS requires circadian worsening at rest and relief by movement. Meta-analyses show only a modest prevalence increase (~8%) in diabetics, far less than pregnancy. Students often conflate neuropathic pain with RLS.  <br><br>D. Chronic obstructive pulmonary disease  <br>&ndash; COPD lacks mechanistic or epidemiological association with RLS. Hypoxia does not trigger classic RLS features. Common error: assuming any discomfort at rest equals RLS.</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Comparison Table</h3><div class="explanation-content"><div class='table-container'><table class='comparison-table'><thead><tr><th>Feature</th><th>Pregnancy (Correct)</th><th>Hypertension</th><th>Diabetes Mellitus</th><th>COPD</th></tr></thead><tbody><tr><td>Prevalence Increase</td><td>10&ndash;34% in 3rd trimester vs ~5% baseline</td><td>No significant change</td><td>~8% (linked to neuropathy)</td><td>No documented increase</td></tr><tr><td>Mechanistic Link</td><td>Iron deficiency, hormonal modulation</td><td>None identified</td><td>Secondary neuropathy effects</td><td>None identified</td></tr><tr><td>Post-condition Resolution</td><td>Resolves 4&ndash;6 weeks postpartum</td><td>Chronic</td><td>Persistent unless neuropathy treated</td><td>Chronic</td></tr></tbody></table></div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Clinical Pearls</h3><div class="explanation-content"><div class='explanation-content'>&bull; RLS symptoms peak in the evening due to circadian dips in CNS iron and dopamine.  <br>&bull; Always measure ferritin; aim for >75 ng/mL before initiating dopaminergic therapy.  <br>&bull; Pregnancy-associated RLS often resolves postpartum&mdash;focus on nonpharmacologic measures and iron repletion.</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Common Pitfalls and Misconceptions</h3><div class="explanation-content"><div class='explanation-content'>1. Confusing diabetic peripheral neuropathy (constant, burning pain) with RLS (circadian, rest-induced, relieved by movement).  <br>2. Overlooking transient causes&mdash;students may mislabel all RLS as idiopathic and miss reversible conditions like pregnancy or iron deficiency.</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Latest Guidelines and Trials</h3><div class="explanation-content"><div class='explanation-content'>1. American Academy of Sleep Medicine (AASM) Clinical Practice Guideline, 2016  <br>   &ndash; Recommendation: Check serum ferritin in RLS; supplement if <75 ng/mL (Level A evidence).  <br>2. Koch et al., Obstetrics & Gynecology, 2018 (Randomized Trial)  <br>   &ndash; Intravenous ferric carboxymaltose in iron-deficient pregnant women reduced RLS severity scores by &ge;30% at 4 weeks (p<0.01).</div></div><div class='explanation-section'></div></div><div class="explanation-section"><h3 class="explanation-header">Board Examination Focus</h3><div class="explanation-content"><div class='explanation-content'>This question appeared in Part 2 2020 exam. RLS associations&mdash;especially pregnancy and iron deficiency&mdash;are frequently tested in both recall and clinical vignette formats. Recognizing secondary causes is a high-yield topic.</div></div></div></div></div>
    </div>
</body>
</html>
